A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL

NCT00774332 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

37

Enrollment

NETWORK

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: CODOX-M

Sponsor

Cooperative Study Group A for Hematology